HBsAg/HBsAb double positive hepatitis B virus infection model in vitro and in vivo

Abstract

The pathogenesis of HBsAg (+)/HBsAb (+) double positive hepatitis B virus infection was investigated by simulating HBsAg/HBsAb coexistence in vitro and establishing HBsAg/HBsAb double positive model in vivo. Eukaryotic expression plasmids PCI-SY, PCI-adw, PCI-adr, PCI-ayw, which expressed S gene product of different serotypes, were constructed and transfected into HepG2 cells. Recombinant proteins were purified from the transfected cells. At the same time, HBsAg mouse antiserum was obtained by immunizing mice with PCI-SY plasmid. HBsAg/HBsAb coexistence was simulated using these antigens and antiserum. Furthermore, the expression plasmids expressing different serotypes of S gene product including PCI-adw, PCI-adr, and PCI-ayw were injected into mice via tail vein. HBsAg and HBsAb in mice sera were tested at the first and 7th day respectively after antigen plasmids injection. Both in vitro simulation and in vivo animal models demonstrated that HBsAg antigen and HBsAb of the same serotypes could not coexist, but HBsAg antigen and HBsAb of different serotype could coexist. HBsAg/HBsAb double positive hepatitis B virus infection could be due to infection of viruses of different serotypes.

Keywords

hepatitis B virus / HBsAg / HBsAb / serotype / model

References

[1] LavanchyD.. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat, 2004, 11(2): 97-107

[2] LaiC.L., RatziuV., YuenM.F., et al.. Viral hepatitis B. Lancet, 2003, 362(9401): 2089-2094

[3] RehermannB., NascimbeniM.. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol, 2005, 5(3): 215-229

[4] HollingerF., LiangT.Hepatitis B Virus, 20014Philadelphia, Lippincott-Williams & Williams Publishers: 2971-3036

[5] TaborE., GeretyR.J., SmallwoodL.A., et al.. Coincident hepatitis B surface antigen and antibodies of different subtypes in human serum. J Immunol, 1977, 118(1): 369-370

[6] MoraczewskaZ., MadalinskiK., HollandP.V.. Simultaneous presence in serum of HBsAg and anti-HBs of different specificities. Intervirology, 1978, 9(3): 189-192

[7] Couroucé-PautyA.M., DrouetJ., KleinknechtD.. Simultaneous occurrence in the same serum of hepatitis B surface antigen and antibody to hepatitis B surface antigen of different subtypes. J Infect Dis, 1979, 140(6): 975-978

[8] FoutchP.G., CareyW.D., TaborE., et al.. Concomitant hepatitis B surface antigen and antibody in thirteen patients. Ann Intern Med, 1983, 99(4): 460-463

[9] ShielsM.T., TaswellH.F., CzajaA.J., et al.. Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B virus. Gastroenterology, 1987, 93(4): 675-680

[10] KohnoH., InoueT., TsudaF., et al.. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B. J Gen Virol, 1996, 77(Pt8): 1825-31

[11] MathetV.L., FeldM., EspinolaL., et al.. Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating anti-HBs antibodies. J Med Virol, 2003, 69(1): 18-26

[12] MesenasS.J., ChowW.C., ZhaoY., et al.. Wild-type and “a” epitope variants in chronic hepatitis B virus carriers positive for hepatitis B surface antigen and antibody. J Gastroenterol Hepatol, 2002, 17(2): 148-152

[13] WangY.M., NgW.C., LoS.K.. Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen. J Gastroenterol, 1999, 34(5): 600-606

[14] YamamotoK., HorikitaM., TsudaF., et al.. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol, 1994, 68(4): 2671-2676

[15] LadaO., BenhamouY., PoynardT., et al.. Coexistence of hepatitis B surface antigen (HBsAg) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of “a” determinant variants. J Virol, 2006, 80(6): 2968-2975

[16] MimmsL.. Hepatitis B virus escape mutants: pushing the envelope of chronic hepatitis B virus infection. Hepatology, 1995, 21(3): 884-887

[17] ZhangJ.M., XuY., WangX.Y., et al.. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Clin Infect Dis, 2007, 44(9): 1161-1169

[18] YuY.C., MaS.W., WangZ.H.. HBsAg and HBsAb coexistence in Chinese patients with chronic HBV infection: clinical and virological characteristics. J Gastroenterol Hepatol, 2006, 21(Suppl2): A143

[19] ShengG.X., ZhouY.L.Modern Immunology Experiment Technology (Chinese), 20022Wuhan, Hubei Science & Technology Publishers: 317-326

[20] MengZ.J., LiL., LiX.Y., et al.. Development of a mouse model for acute hepatitis B virus infection (Chinese). Virologica Sinica, 2005, 20(6): 565-569

[21] YangP.L., AlthageA., ChungJ., et al.. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci, 2002, 99(21): 13 825-13 830